Sodium-glucose co-transporter 2 inhibition - A novel strategy for glucose control in type 2 diabetes

Medicine and Dentistry

• Glycemic Control 100%
• Maturity Onset Diabetes of the Young 100%
• Glucose 66%
• Combination Therapy 66%
• Hypoglycemia 66%
• Beta Cell 66%
• Microvascular Complication 66%
• Mechanism of Action 66%
• Diseases 33%
• Hyperglycemia 33%
• Pathogenesis 33%
• Side Effect 33%
• Antidiabetic Agent 33%
• Sodium Glucose Cotransporter 2 33%
• Development 33%
• Glucosuria 33%
• Glucotoxicity 33%
• Oral Antidiabetic Agent 33%
• Sodium Glucose Cotransporter 33%
• Tissues 33%
• Incidence 33%
• Plasma 33%
• Weight Loss 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Glucose 66%
• Hypoglycemia 66%
• Diseases 33%
• Insulin 33%
• Side Effect 33%
• Pathogenesis 33%
• Hyperglycemia 33%
• Glucosuria 33%
• Sodium Glucose Cotransporter 2 33%
• Antidiabetic Agent 33%
• Oral Antidiabetic Agent 33%
• Glucotoxicity 33%
• Incidence 33%
• Sodium Glucose Cotransporter 33%